The DOI matches its Crossref record; 17 of the 18 references it cites were found in a registry or an index.
Evaluation of the Modified Fatigue Impact Scale in four different European countries
Abstract
OBJECTIVE: To evaluate the psychometric properties of the Modified Fatigue Impact Scale (MFIS) in four different European countries. METHODS: Individuals with definite multiple sclerosis (MS) were selected from centres in Italy (n =50), Spain (n =30), Slovenia (n =50) and Belgium (n =51) and completed the MFIS and the Fatigue Severity Scale (FSS) twice (interval < or =3 days). RESULTS: In all four samples, the MFIS demonstrated a good reproducibility (intraclass correlation coefficient > or = 0.84), with no significant differences between countries (P =0.77). Moderate correlations were found between the MFIS and FSS. No significant correlations were found between the MFIS and age, gender, type of MS, duration of the disease or EDSS score. Factor analysis of all samples (n = 181) could not completely confirm the original assumptions concerning the physical, cognitive and psychosocial component The total score, the physical and the cognitive subscale of the scale were homogeneous (Cronbach's alpha 0.92, 0.88 and 0.92, respectively), but the psychosocial subscale had a Cronbach's alpha of 0.65. CONCLUSIONS: No cultural or linguistic differences were found in the psychometric properties of the Belgian, Italian, Slovenian or Spanish version of the MFIS. We recommend this scale for research purposes and in clinical practice. Due to the limited value of the psychosocial subscale, we recommend interpreting this subscale with caution.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Fatigue will be studied using the Modified Fatigue Impact Scale (34), an abbreviated version of the longer, previous Fatigue Impact Scale, with demonstrated satisfactory validity and internal consistency (35).”
Citations
Cites
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032
Krupp, L. B. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520460115022 · Cited by 6,172
Measuring the Functional Impact of Fatigue: Initial Validation of the Fatigue Impact Scale
Fisk, J. D., Ritvo, P. G., Ross, L., Haase, D. A., Marrie, T. J., & Schlech, W. F. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.supplement_1.s79 · Cited by 1,546
The impact of fatigue on patients with multiple sclerosis
Fisk, J. D., Pontefract, A., Ritvo, P. G., Archibald, C. J., & Murray, T. J. (1994) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100048691 · Cited by 1,025
Krupp, L., Alvarez, L., LaRocca, N. G., & Lc, S. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520280085020 · Cited by 999
Rankin, G., & Stokes, M. J. (1998) · Clinical Rehabilitation · doi:10.1191/026921598672178340 · Cited by 855
Flachenecker, P., Kümpfel, T., Kallmann, B. A., Gottschalk, M., Grauer, O. M., Rieckmann, P., Trenkwalder, C., & Toyka, K. V. (2002) · Multiple Sclerosis Journal · doi:10.1191/1352458502ms839oa · Cited by 635
Symptomatic fatigue in multiple sclerosis.
Freal, J. E., Kraft, G. H., & Coryell, J. K. (1984) · PubMed · Cited by 526
Rammohan, K. W. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.2.179 · Cited by 441
A randomized controlled study of the acute and chronic effects of cooling therapy for MS
NASA/MS Cooling Study Group* (2003) · Neurology · doi:10.1212/01.wnl.0000070183.30517.2f · Cited by 132
Research works printed but not linked: 5
- Krupp LB., 2003, Fatigue
- Bergamaschi R, 1997, Funct Neurol, 12, 247
- Freal JE, 1984, Arch Phys Med Rehabil, 65, 135
- 10.1177/135245850200800107 · DOI
- Kos D, 2003, Acta Neurol Belg, 103, 185
Cited by
Sorted by citations
Items 201–300 of 381
Crispiatico, V., Baldanzi, C., Napoletano, A., Tomasoni, L., Tedeschi, F., Groppo, E., Rovaris, M., Vitali, C., & Cattaneo, D. (2021) · Multiple Sclerosis Journal · doi:10.1177/13524585211051059 · Cited by 10
Veldman, M. H. J., van der Aa, H. P. A., Bode, C., Knoop, H., Hulshof, C. T. J., Koopmanschap, M. A., Stavleu, E., van Rens, G. H. M. B., & van Nispen, R. M. A. (2021) · Trials · doi:10.1186/s13063-021-05935-w · Cited by 10
Strober, L. B., & Callanan, R. (2019) · Journal of Health Psychology · doi:10.1177/1359105319876340 · Cited by 10
Low serum 25‑hydroxy-vitamin D levels are associated with cognitive impairment in multiple sclerosis
Spiezia, A. L., Falco, F., Manganelli, A., Carotenuto, A., Petracca, M., Novarella, F., Iacovazzo, C., Servillo, G., Lanzillo, R., Morra, V. B., et al. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.105044 · Cited by 10
van Zuuren, E. J., Fedorowicz, Z., Pucci, E., Jagannath, V. A., & Robak, E. W. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009903.pub2 · Cited by 9
VanNostrand, M., Sogoloff, B., Giroux, C., Bergmans, L., & Kasser, S. L. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.104115 · Cited by 9
Bellew, D., Davenport, L., Monaghan, R., Cogley, C., Gaughan, M., Yap, S. M., Tubridy, N. J., Bramham, J., McGuigan, C., & O’Keeffe, F. M. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.104161 · Cited by 10
Veldman, M. H. J., van der Aa, H. P. A., Knoop, H., Bode, C., Hulshof, C. T. J., van der Ham, A. J., van Rens, G. H. M. B., Heymans, M. W., & van Nispen, R. M. A. (2023) · BMC Health Services Research · doi:10.1186/s12913-023-10193-4 · Cited by 9
Fatigue bei Multipler Sklerose
Flachenecker, P. (2015) · Nervenheilkunde · doi:10.1055/s-0038-1627622 · Cited by 9
Sgoifo, A., Bignamini, A., Mantia, L. L., Celani, M. G., Parietti, P., Ceriani, M. A., Marazzi, M. R., Proserpio, P., Nobili, L., Protti, A., et al. (2017) · Neurology and Therapy · doi:10.1007/s40120-017-0081-9 · Cited by 8
Blikman, L. J., van Meeteren, J., Rizopoulos, D., de Groot, V., Beckerman, H., Stam, H. J., & Bussmann, J. B. J. (2018) · Journal of Rehabilitation Medicine · doi:10.2340/16501977-2375 · Cited by 9
Gil‐Perotín, S., Reddam, S., González‐Mingot, C., Gil-Sánchez, A., González‐Suarez, I., Peralta, S., Escrivá, P., Moya, L. B., & Sánchez-Sánchez, B. (2023) · BMC Women s Health · doi:10.1186/s12905-023-02811-4 · Cited by 7
Matías‐Guiu, J. A., González-Rosa, J. J., Hernández, M. Á., Martínez‐Ginés, M. L., Portolés, A., Pérez-Macías, N., Benito‐León, J., Padrón, I., Prieto, J., & Matías‐Guiu, J. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-078661 · Cited by 8
Piscitelli, D., Brichetto, G., Geri, T., Battista, S., Testa, M., Bragadin, M. M., & Pellicciari, L. (2024) · Disability and Rehabilitation · doi:10.1080/09638288.2024.2302878 · Cited by 9
Amygdala network reorganization mediates the theory of mind performances in multiple sclerosis
Koubiyr, I., Dulau, C., Deloire, M., Charré‐Morin, J., Saubusse, A., Brochet, B., & Ruet, A. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24986 · Cited by 8
Assessing the impacts of L-carnitine and modafinil on fatigue in Iraqi multiple sclerosis patients
Al-Shammari, A. H., Abbood, Z., & Lateef, H. F. (2023) · Journal of Advanced Pharmaceutical Technology amp Research · doi:10.4103/japtr.japtr_225_23 · Cited by 8
Fatigue evaluation in fingolimod treated patients: An observational study
Masingue, M., Debs, R., Maillart, É., Delvaux, V., Lubetzki, C., Vidal, J., & Papeix, C. (2017) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2017.03.006 · Cited by 8
Derksen, A., Mokkink, L. B., Rietberg, M. B., Knol, D. L., Ostelo, R., & Uitdehaag, B. M. J. (2013) · Quality of Life Research · doi:10.1007/s11136-013-0375-z · Cited by 8
Profiles of Individuals With Long COVID Reporting Persistent Cognitive Complaints
Fernandez, C. C., Didone, V., Slama, H., Dupuis, G., Fery, P., Delrue, G., Lesoinne, A., Collette, F., & Willems, S. J. (2025) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acaf064 · Cited by 9
Niemczak, C. E., Ford, J., Roth, R. M., Leigh, S. M., Parsonnet, J., Martin, C. Y., Soule, S. O., Haron, T. M., Buckey, J. C., & Wylie, G. R. (2024) · Brain and Cognition · doi:10.1016/j.bandc.2024.106254 · Cited by 8
Dinoto, A., Baldini, S., Morelli, M. E., Pasquin, F., Bratina, A., Bosco, A., Sartori, A., & Manganotti, P. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05487-6 · Cited by 7
Özdoğar, A. T., Kahraman, T., Özakbaş, S., Achiron, A., & Kalron, A. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103456 · Cited by 7
Exploring the relation between reserve and fatigue in multiple sclerosis
Tranfa, M., Iuzzolino, V. V., Perrella, P. P., Carotenuto, A., Pontillo, G., Moccia, M., Cocozza, S., Elefante, A., Lanzillo, R., Brunetti, A., et al. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104842 · Cited by 7
Masuda, H., Mori, M., Uzawa, A., Muto, M., Uchida, T., Kobayashi, S., & Kuwabara, S. (2015) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12236 · Cited by 7
Outcome measures for multiple sclerosis
Osborne, L. A., Noble, J. G., Maramba, I. D. C., Jones, K. H., Middleton, R., Lyons, R. A., Ford, D. V., & Reed, P. (2013) · Physical Therapy Reviews · doi:10.1179/1743288x13y.0000000094 · Cited by 7
Hochsprung, A., Escudero‐Uribe, S., Ibáñez‐Vera, A. J., & Izquierdo‐Ayuso, G. (2018) · Neurología · doi:10.1016/j.nrl.2018.03.003 · Cited by 7
Sigurdardottir, A. H., Knudtzen, F. C., Nymark, A., & Bang, M. (2022) · Brain and Behavior · doi:10.1002/brb3.2719 · Cited by 7
Validation of the Modified Fatigue Impact Scale in patients with systemic lupus erythematosus
Junker, C. I., Dreyer, L., Duch, K. S., Gregersen, J. W., & Kristensen, S. (2022) · Lupus · doi:10.1177/09612033221127650 · Cited by 6
Nylander, A. N., Sisodia, N., Henderson, K., Wijangco, J., Koshal, K., Poole, S. T., Dias, M., Linz, N., Tröger, J., König, A., et al. (2024) · Multiple Sclerosis Journal · doi:10.1177/13524585241303855 · Cited by 6
Predictors of performance and perceived fatigability in people with multiple sclerosis
Abou, L., Fritz, N. E., & Kratz, A. L. (2023) · Neurological Research · doi:10.1080/01616412.2023.2252283 · Cited by 6
Vanbilsen, N., Moumdjian, L., Kinnaert, F., Degens, B., Moens, B., Goetschalckx, M., Kos, D., Wijmeersch, B. V., Leman, M., & Feys, P. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.106152 · Cited by 6
The effect of Benson relaxation technique on fatigue of patients diagnosed with multiple sclerosis
Alzaghmouri, A. H., Masa’Deh, R., Jaberi, M. A., Masadeh, O., Smadi, A. A., & Alshawabkeh, G. A. (2021) · Journal of Health Sciences · doi:10.17532/jhsci.2021.1229 · Cited by 6
Ng, S. S. M., Liu, T. W., & Tsoh, J. (2022) · BMC Neurology · doi:10.1186/s12883-022-02832-w · Cited by 6
Muñoz-Paredes, I., Herrero, A. J., Román-Nieto, N., Peña-Gomez, A. M., & Seco‐Calvo, J. (2022) · Healthcare · doi:10.3390/healthcare11010084 · Cited by 6
A virtual reality program to assess cognitive function in multiple sclerosis: A pilot study
Hsu, W., Anguera, J. A., Rizzo, A., Campusano, R., Chiaravalloti, N. D., DeLuca, J., Gazzaley, A. H., & Bove, R. M. (2023) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2023.1139316 · Cited by 6
Daytime sleepiness and sleep quality in Charcot–Marie–Tooth disease
Bellofatto, M., Gentile, L., Bertini, A., Tramacere, I., Manganelli, F., Fabrizi, G. M., Schenone, A. E., Santoro, L., Cavallaro, T., Grandis, M., et al. (2023) · Journal of Neurology · doi:10.1007/s00415-023-11911-y · Cited by 6
Cano‐de‐la‐Cuerda, R., Jiménez‐Antona, C., Ortiz, A. M., Molero‐Sánchez, A., de Miguel, Á. G., Lizcano‐Álvarez, A., Hernández‐Barrera, V., Varillas‐Delgado, D., & Laguarta-Val, S. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm12010131 · Cited by 6
Understanding fatigue in multiple sclerosis: new insights in causes and assessment
Colombo, B., Annovazzi, P. O. L., & Comı, G. (2006) · Neurological Sciences · doi:10.1007/s10072-006-0646-3 · Cited by 6
Developing a Wellness Program for People with Multiple Sclerosis
Hart, D. L., Memoli, R. I., Mason, B., & Werneke, M. W. (2011) · International Journal of MS Care · doi:10.7224/1537-2073-13.4.154 · Cited by 6
Håkansson, A., Cronhjort, M., Lidin-Darlington, P., Lilja, G., Nilsson, A., Schandl, A., & Friberg, H. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.907215 · Cited by 5
“Fatigue will be studied using the Modified Fatigue Impact Scale (34), an abbreviated version of the longer, previous Fatigue Impact Scale, with demonstrated satisfactory validity and internal consistency (35).”
MethodDoskas, T. K., Christidi, F., Spiliopoulos, K. C., Tsiptsios, D., Vavougios, G. D., Tsiakiri, A., Vorvolakos, T., Kokkotis, C., Iliopoulos, I., Aggelousis, N., et al. (2023) · Neurology International · doi:10.3390/neurolint15030068 · Cited by 5
Validating the Fatigue Scale for Motor and Cognitive Function (FSMC) in chronic stroke
Goh, H., Stewart, J. C., & Becker, K. A. (2023) · Neurorehabilitation · doi:10.3233/nre-230189 · Cited by 8
Schlegel, M., Weippert, M., Feldhege, F., Knaack, F., Mittlmeier, T., Bruhn, S., & Behrens, M. (2025) · GeroScience · doi:10.1007/s11357-024-01452-1 · Cited by 5
Prolonged Fatigue and Mental Health Challenges in Critical COVID-19 Survivors
Hultgren, M., Didriksson, I., Håkansson, A., Andertun, S. G., Frigyesi, A., Mellerstedt, E., Nelderup, M., Nilsson, A. C., Reepalu, A., Spångfors, M., et al. (2024) · Journal of Intensive Care Medicine · doi:10.1177/08850666241255328 · Cited by 5
Le, H. H., Stocks, S. J., & Ait-Tihyaty, M. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.105846 · Cited by 5
Buchanan, R. J., Zúñiga, M. Á., Carrillo, G., Chakravorty, B. J., Tyry, T. M., Moreau, R., Huang, C., & Vollmer, T. L. (2010) · Cited by 5
Weygandt, M., Behrens, J. R., Brasanac, J., Söder, E., Meyer‐Arndt, L., Wakonig, K. M., Ritter, K., Brandt, A. U., Bellmann–Strobl, J., Gold, S. M., et al. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.05.025 · Cited by 5
Alshamrani, F., Almuaigel, M. F., Al-Khamis, F. A., Al-Sulaiman, A., AlMohish, N. M., Albuhassah, A. F., Alzahrani, A., & Zaher, A. A. M. (2020) · Saudi Medical Journal · doi:10.15537/smj.2020.3.24910 · Cited by 5
Guía para el seguimiento de la enfermedad de Pompe de inicio tardío
Gutiérrez‐Rivas, E., Illa, I., Pascual, S. I. P., Pérez‐López, J., Vilchez, J. J., Lorite, J. B., Cortés, E. B., & de Munaín, A. L. (2015) · Revista de Neurología · doi:10.33588/rn.6007.2015029 · Cited by 5
Adaptación y validación de la escala de impacto de fatiga
Ayala, R. E. D., Velasco-Rojano, Á. E., Sosa, J. J. S., & Lagunes, L. I. R. (2017) · Acta de Investigación Psicológica · doi:10.1016/j.aipprr.2017.02.002 · Cited by 5
Betti, M., Masciulli, C., Addazio, I., Ballerini, C., Bonacchi, R., Caporali, A., Chiappetta, F., Meo, E. D., Fabbiani, C., Gerli, F., et al. (2026) · Neurological Sciences · doi:10.1007/s10072-026-08988-4 · Cited by 4
Oliver‐Mas, S., Matías‐Guiu, J. A., Delgado‐Alonso, C., Cuevas, C., del Puerto, J. M. A. R., López‐Carbonero, J. I., Matías‐Guiu, J., & Díez‐Cirarda, M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14030952 · Cited by 4
Moumdjian, L., Six, J., Veldkamp, R., Geys, J., Linden, C. V. D., Goetschalckx, M., Nieuwenhoven, J. V., Bosmans, I., Leman, M., & Feys, P. (2022) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14777 · Cited by 4
Systematic review: patient-reported outcome measures of fatigue in inflammatory bowel disease
Fan, V. S. K., Mehdipour, A., O’Grady, H. K., Richardson, J. A., Griffith, L. E., Campbell, K. L., & Bosch, J. (2022) · Fatigue Biomedicine Health & Behavior · doi:10.1080/21641846.2022.2073157 · Cited by 4
Muñoz-Paredes, I., Herrero, A. J., & Seco‐Calvo, J. (2023) · Healthcare · doi:10.3390/healthcare11101384 · Cited by 4
Fatigue and Physical Activity in People after COVID-19 in Poland
Zalewska, A., & Gałczyk, M. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13091369 · Cited by 4
Gasión, V., Barceló‐Soler, A., Beltrán-Ruiz, M., Hijar-Aguinaga, R., Camarero-Grados, L., del Hoyo, Y. L., García‐Campayo, J., & Montero‐Marín, J. (2023) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-023-04240-0 · Cited by 5
Identifying neuropsychological phenotypes in multiple sclerosis using latent profile analysis
Spiezia, A. L., Pontillo, G., Falco, F., Eliano, M., Lamagna, F., Esposito, A., Monaco, C. D., Nicolella, V., Novarella, F., Moccia, M., et al. (2025) · European Journal of Neurology · doi:10.1111/ene.70009 · Cited by 5
Superficial Neuromodulation in Dysautonomia in Women with Post-COVID-19 Condition: A Pilot Study
Ortiz, A. M., Zurdo-Sayalero, E., Perpiñá-Martínez, S., Delgado-Lacosta, A., Jiménez‐Antona, C., Fernández‐Carnero, J., & Laguarta-Val, S. (2025) · Brain Sciences · doi:10.3390/brainsci15050510 · Cited by 4
Validación psicométrica de la Escala de gravedad de fatiga en médicos residentes mexicanos
Duarte, R. E., Velasco, E., Sosa, J. J. S., & Lagunes, L. I. R. (2018) · Educación Médica · doi:10.1016/j.edumed.2017.11.006 · Cited by 4
Monjezi, S., Molhemi, F., Yazdi, M. J. S., Salehi, R., Mehravar, M., & Kashipazha, D. (2020) · Physiotherapy Theory and Practice · doi:10.1080/09593985.2020.1762267 · Cited by 4
Knippenberg, E., Timmermans, A. A. A., Coolen, J., Neven, K., Hallet, P., Lemmens, J., & Spooren, A. I. F. (2021) · Journal of NeuroEngineering and Rehabilitation · doi:10.1186/s12984-021-00977-2 · Cited by 4
Grunden, N., Calabria, M., García‐Sánchez, C., Pons, C., Arroyo, J. A., Gómez‐Ansón, B., García, M. D. C. E., Belvís, R., Morollón, N., Cordero-Carcedo, M., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0302415 · Cited by 4
Potential Benefits of Nintendo Wii Fit Among People with Multiple Sclerosis
Plow, M. A., & Finlayson, M. L. (2013) · International Journal of MS Care · doi:10.7224/1537-2073-15.s1.13 · Cited by 4
Brichetto, G., Rinaldi, S., Spallarossa, P., Battaglia, M. A., & de Carvalho, M. L. L. (2013) · Neurorehabilitation · doi:10.3233/nre-130933 · Cited by 4
SLEEP DISTURBANCE IN MULTIPLE SCLEROSIS
Cowan, P. (2009) · Cited by 4
La educación en la obra de Josefa Amar y Borbón
Frago, A. V. (2003) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 4
Natalizumab for relapsing remitting multiple sclerosis
Pucci, E., Giuliani, G., Solari, A., Pietrantonj, C. D., Simi, S., Minozzi, S., & Galea, I. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007621 · Cited by 4
van Zuuren, E. J., Fedorowicz, Z., Pucci, E., Jagannath, V. A., & Robak, E. W. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009903 · Cited by 4
López-Soley, E., Martínez‐Heras, E., Vivó, F., Calvi, A., Albà-Arbalat, S., Romero-Pinel, L., Martínez‐Yélamos, S., Ramo-Tello, C. M., Presas‐Rodríguez, S., Munteis, E., et al. (2025) · NeuroImage Clinical · doi:10.1016/j.nicl.2025.103775 · Cited by 3
Hvid, L. G., Coote, S. B., Pau, M., & Kalron, A. (2025) · JMIR Research Protocols · doi:10.2196/75983 · Cited by 3
Uhlenbusch, N., Snijders, R. J. A. L. M., Mund, M., Janik, M. K., Milkiewicz, P., Löwe, B., Kroll, C., Raszeja‐Wyszomirska, J., Gerussi, A., Bolis, F., et al. (2026) · Liver International · doi:10.1111/liv.70526 · Cited by 3
Galperin, I., Buzaglo, D., Gazit, E., Shimoni, N., Tamir, R., Regev, K., Karni, A., & Hausdorff, J. M. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12339-8 · Cited by 3
Sundström, B., Johansson, S., & Wallin, A. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.106210 · Cited by 3
Frequency and risk factors of sleep problems in Egyptian patients with multiple sclerosis
Khedr, E. M., Ahmed, G. K., Hassan, S. S., Foly, M. N., Attia, M. M., Karim, A. A., & Haridy, N. A. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1563041 · Cited by 3
Validación de la Escala de Gravedad de Fatiga en Población General de la Ciudad de México
Velasco-Rojano, Á. E., Duarte-Ayala, R. E., Riveros-Rosas, A., Sánchez-Sosa, J. J., & Reyes-Lagunes, L. I. (2017) · Revista Evaluar · doi:10.35670/1667-4545.v17.n2.18725 · Cited by 3
Chung, Y. H., Jeong, A., Kim, B. J., Park, K., & Min, J. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.103811 · Cited by 3
Behrendt, T., Bielitzki, R., Behrens, M., Jahns, L.-M., Boersma, M., & Schega, L. (2024) · PeerJ · doi:10.7717/peerj.18027 · Cited by 3
Silva‐Batista, C., Arpan, I., Nucci, M. P., & Horak, F. B. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.12.036 · Cited by 4
Kos, D., Ferdinand, S., Duportail, M., Eijssen, I. C. J. M., Schouteden, S., Kerkhofs, L., Janša, J., Filló, N., Matuska, K., & Beckerman, H. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.101879 · Cited by 3
Symptomatic Treatment in Multiple Sclerosis
Bigi, S., & Yeh, E. A. (2013) · touchREVIEWS in Neurology · doi:10.17925/usn.2013.09.01.35 · Cited by 5
Defining a standard set of health outcomes for patients with relapsing-remitting multiple sclerosis
González, M. L., Carrascal, P., Sánchez, O. D., Guerra, M. B., Antigüedad, A. R., Baladrón, A. M., Ríos, N. B., Rovira, À., Lallana, V. M., Benedito‐Palos, L., et al. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.105501 · Cited by 2
de Jesus, V. E. A., Ribeiro, M. D. C. R., Lana, R. D. C., Schaper, F. C., Amaral, J. S., Azevedo, S. G., Vieira, R. G. K., & Aguiar, L. T. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.105674 · Cited by 2
Tacchino, A., Ponzio, M., Confalonieri, P. A., Leocani, L., Inglese, M., Centonze, D., Cocco, E. E., Gallo, P., Paolicelli, D., Rovaris, M., et al. (2024) · JMIR Research Protocols · doi:10.2196/58026 · Cited by 2
Abonie, U. S., Ackah, M., & Kelly, M. C. (2025) · Disability and Rehabilitation · doi:10.1080/09638288.2025.2512406 · Cited by 2
Moumdjian, L., Moens, B., Manto, M., Cabaraux, P., Wijmeersch, B. V., Kos, D., Leman, M., & Feys, P. (2025) · Scientific Reports · doi:10.1038/s41598-025-12316-9 · Cited by 3
Antal, A., Ramasawmy, P., Rubal‐Otero, L., Chakalov, I., Rodríguez, M. Á., Hunold, A., Schellhorn, K., & Carrillo‐de‐la‐Peña, M. T. (2025) · BMC Cancer · doi:10.1186/s12885-025-15143-3 · Cited by 2
Romigi, A., Bassi, M. S., Caccamo, M., Gilio, L., Ceriello, F., Finardi, A., Vitrani, G., Rosenzweig, I., Furlan, R., Buttari, F., et al. (2025) · Journal of Sleep Research · doi:10.1111/jsr.70248 · Cited by 2
The critical role of the basal ganglia in post-stroke fatigue: A pilot study
Boukrina, O. V., DeLuca, J., & Wylie, G. R. (2025) · Neuroimage Reports · doi:10.1016/j.ynirp.2025.100313 · Cited by 2
Johnsen, P. H., Juul, F. E., Hoff, D. A. L., Hillestad, E. M. R., Holme, Ø., Skjevling, L. K., Hansen, H. M., Rasmus, M. H., Barnett, L., Barry, S. J. E., et al. (2026) · The Lancet · doi:10.1016/s0140-6736(26)01424-8 · Cited by 2
Meca-Lallana, J. E., Prieto-González, J. M., Jiménez-Veiga, J., Guarnizo, E. C., Martín, I. J., Hernández-Clares, R., Sistiaga, A., Díes, R. C., García-Molina, E., Sánchez, M. C., et al. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.12.003 · Cited by 2
Perucca, L., Scarano, S., Russo, G. M., Majnardi, A. R., & Caronni, A. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1274809 · Cited by 2
Falco, F., Lamagna, F., Espósito, A., Eliano, M., Spiezia, A. L., Petracca, M., Caliendo, D., Moccia, M., Lanzillo, R., Morra, V. B., et al. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.105769 · Cited by 2
The impact of fatigue on people with multiple sclerosis in Morocco
Lotfi, R., Amgharia, H. B., Ennaciri, S., Chikhaoui, M., Kardoudi, A. E., & Chigr, F. (2024) · African Journal of Disability · doi:10.4102/ajod.v13i0.1376 · Cited by 3
Association between CD20 + T lymphocytes and neuropsychological findings in multiple sclerosis
Esposito, A., Falco, F., Scalia, G., Gentile, L., Spiezia, A. L., Corsini, G., Manganiello, R., Eliano, M., Lamagna, F., Moccia, M., et al. (2024) · European Journal of Neurology · doi:10.1111/ene.16536 · Cited by 2
Broche‐Pérez, Y., Jiménez-Morales, R. M., Monasterio-Ramos, L. O., Gómez, L. A. V., & Fernández-Fleites, Z. (2024) · Neurología · doi:10.1016/j.nrl.2022.06.005 · Cited by 2
Massalha, H., Menascu, S., Dreyer-Alster, S., Aloni, R., & Kalron, A. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.106189 · Cited by 2
Lallana, J. E. M., Eichau, S., Casanova, B., Rodríguez, E. Á., Pato, A. P., Forner, M., & Toledo, B. (2024) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-024-00822-9 · Cited by 2
Frutos, M. D. L. P. S., Sanz-Esteban, I., Salniccia, F., Bermejo-Franco, A., García-Corona, A., Palma-Baquedano, M. C., Castel-Sánchez, M., & Estrada-Barranco, C. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2024.1529057 · Cited by 2
Neurobehavioral mechanisms of fear and anxiety in multiple sclerosis
Meyer‐Arndt, L., Rust, R., Bellmann–Strobl, J., Schmitz‐Hübsch, T., Markó, L., Forslund, S. K., Scheel, M., Gold, S. M., Hetzer, S., Paul, F., et al. (2025) · Communications Medicine · doi:10.1038/s43856-025-01085-1 · Cited by 2
Metadata
- Authors
- Kos, D., Kerckhofs, E., Carrea, I., Verza, R., Ramos, M., & Jansa, J.
- Affiliations
- Vrije Universiteit Brussel (BE)
- Associazione Italiana Sclerosi Multipla (IT)
- Hospital de Dia de Esclerosi Multiple, C/Teodora Lamadrid 21=23, 08022 Barcelona, Spain
- Department of Neurology, University Medical Centre Ljubljana, Zaloska 2, 1000 Ljubljana, Slovenia
- Corresponding author
- Kos, D
- ORCID
- Venue
- Multiple Sclerosis Journal
- Publisher
- SAGE Publications
- Published
- 2005-02
- Volume
- 11
- Issue
- 1
- Pages
- 76-80
- ISSN
- 1352-4585 (ISSN-L)
- 1477-0970
- OpenAlex
- W2023604417
- Cited by
- 381
- References
- 18
- Citations by year
- 2026: 31 · 2025: 28 · 2024: 36 · 2023: 22 · 2022: 38 · 2021: 30 · 2020: 24 · 2019: 23 · 2018: 16 · 2017: 16 · 2016: 7 · 2015: 15 · 2014: 9 · 2013: 19 · 2012: 9
- FWCI
- 4.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Multiple Sclerosis Journal (publishedVersion)
- PubMed (publishedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Social Sciences › Decision Sciences › Management Science and Operations Research › Psychometric Methodologies and Testing
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Keywords
- Modified Fatigue Impact Scale, multiple sclerosis, fatigue, psychometric properties, cross-cultural validation, Fatigue Severity Scale, reliability statistics, factor structure, European patients
- MeSH terms
- Adult, Cross-Cultural Comparison, Disability Evaluation, Europe, Evaluation Studies as Topic, Fatigue, Female, Humans, Language, Male, Middle Aged, Multiple Sclerosis, Psychometrics, Reproducibility of Results
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review